These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21683674)

  • 1. Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.
    Caroli A; Antiga L; Conti S; Sonzogni A; Fasolini G; Ondei P; Perico N; Remuzzi G; Remuzzi A
    Am J Pathol; 2011 Aug; 179(2):619-27. PubMed ID: 21683674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.
    Sise C; Kusaka M; Wetzel LH; Winklhofer F; Cowley BD; Cook LT; Gordon M; Grantham JJ
    Kidney Int; 2000 Dec; 58(6):2492-501. PubMed ID: 11115083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
    Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
    Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.
    King BF; Reed JE; Bergstralh EJ; Sheedy PF; Torres VE
    J Am Soc Nephrol; 2000 Aug; 11(8):1505-1511. PubMed ID: 10906164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
    Irazabal MV; Rangel LJ; Bergstralh EJ; Osborn SL; Harmon AJ; Sundsbak JL; Bae KT; Chapman AB; Grantham JJ; Mrug M; Hogan MC; El-Zoghby ZM; Harris PC; Erickson BJ; King BF; Torres VE;
    J Am Soc Nephrol; 2015 Jan; 26(1):160-72. PubMed ID: 24904092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.
    Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA
    BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.
    Sharma K; Rupprecht C; Caroli A; Aparicio MC; Remuzzi A; Baust M; Navab N
    Sci Rep; 2017 May; 7(1):2049. PubMed ID: 28515418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.
    Caroli A; Villa G; Brambilla P; Trillini M; Sharma K; Sironi S; Remuzzi G; Perico N; Remuzzi A
    Eur Radiol; 2023 Sep; 33(9):6009-6019. PubMed ID: 37017703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
    Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
    Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.
    Antiga L; Piccinelli M; Fasolini G; Ene-Iordache B; Ondei P; Bruno S; Remuzzi G; Remuzzi A
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):754-60. PubMed ID: 17699283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume regression of native polycystic kidneys after renal transplantation.
    Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
    Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
    Chebib FT; Torres VE
    Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.